Electrochemotherapy in the Treatment of Cutaneous Metastases from Breast Cancer: A Multicenter Cohort Analysis

Annals of Surgical Oncology

Volumn 22, Issue , 2015, Pages 442-450

  Cabula, C ^a   Campana, L G ^b   Grilz, G ^c   Galuppo, S ^b   Bussone, R ^c   De Meo, L ^d   Bonadies, A ^e   Curatolo, P ^f   De Laurentiis, M ^g   Renne, M ^h   Valpione, S ^b   Fabrizio, T ⁱ   Solari, N ^j   Guida, M ^k   Santoriello, A ^l   D'Aiuto M ^m   Agresti, R ⁿ  

^a Ospedale Oncologico A Businco   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d Humanitas Centro Catanese di Oncologia   (Italy)

^e SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g SECOND UNIVERSITY OF NAPLES   (Italy)

^h Centro Oncologico Fondazione T Campanella   (Italy)

ⁱ REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^j UNIVERSITY OF GENOA   (Italy)

^k Istituto dei Tumori   (Italy)

^l UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^m NATIONAL CANCER INSTITUTE   (Italy)

ⁿ NATIONAL CANCER INSTITUTE   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; ANTINEOPLASTIC AGENT; ERBB2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; COHORT ANALYSIS; EDEMA; ELECTROCHEMOTHERAPY; FEMALE; FEVER; FLU LIKE SYNDROME; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; LUMINAL A BREAST CANCER; LUMINAL B BREAST CANCER; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); NAUSEA; NEEDLE ELECTRODE; PROGRESSION FREE SURVIVAL; RASH; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN INFECTION; SKIN METASTASIS; SKIN PAIN; SKIN TOXICITY; SKIN ULCER; SOFT TISSUE INFECTION; TREATMENT RESPONSE; TRIPLE NEGATIVE BREAST CANCER; TUMOR VOLUME; VISCERAL METASTASIS; VOMITING; BREAST NEOPLASMS; CANCER STAGING; CARCINOMA, DUCTAL, BREAST; CLINICAL TRIAL; FOLLOW UP; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROCEDURES; PROGNOSIS; SECONDARY; SKIN NEOPLASMS; TUMOR INVASION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COHORT STUDIES; ELECTROCHEMOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SKIN NEOPLASMS;

EID: 84951270447     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4779-6     Document Type: Article

References (30)

1. Zagar TM, Higgins KA, Miles EF, et al. Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy. Radiother Oncol. 2010;97:535–40.
2. Oldenborg S, Van Os RM, Van Rij CM, et al. Elective re-irradiation and hyperthermia following resection of persistent locoregional recurrent breast cancer: a retrospective study. Int J Hyperthermia. 2010;26:136–44.
3. Guarneri V, Conte P. Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy. Oncologist. 2009;14:645–56.
4. Leonard R, Hardy J, van Tienhoven G, et al. Randomized, double-blind, placebo-controlled, multicenter trial of 6 % miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J Clin Oncol. 2001;21:4150–9.
5. Mir LM, Orlowski S. Mechanisms of electrochemotherapy. Adv Drug Deliv Rev. 1999;35:107–18.
6. Marty M, Sersa G, Garbay JR, et al. Electrochemotherapy—an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer. 2006;4(suppl 11):3–13.
7. Spratt DE, Gordon Spratt EA, Wu S, et al. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. J Clin Oncol. 2014;32:3144–55.
8. Sersa G, Cufer T, Paulin SM, et al. Electrochemotherapy of chest wall breast cancer recurrence. Cancer Treat Rev. 2012;38:379–86.
9. Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28:2784–95.
10. Cheang MC, Chia SK, Voduc D, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009;101:736–50.
11. Goldhirsh A, Winer EP, Coates AS, et al. Personalising the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer. Ann Oncol. 2013;24:2206–23.
12. Mir LM, Gehl J, Sersa G, et al. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator™ by means of invasive or non-invasive electrodes. Eur J Cancer. 2006;4(suppl 11):14–25.
13. Eisenhauer EA, Therasse P, Bogaerts LH, et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.
14. US Department of Health and Human Services. NIH-NCI. Common Terminology Criteria for Adverse Events (CTCAE). Version 4.0. May 28, 2009. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE.
15. McCaffery M, Pasero C. Pain: clinical manual. 2nd ed. St. Louis: CV Mosby; 1999.
16. Campana LG, Mocellin S, Basso M, et al. Bleomycin-based electrochemotherapy: clinical outcome from a single institution’s experience with 52 patients. Ann Surg Oncol. 2009;16:191–9.
17. Campana LG, Valpione S, Falci C, et al. The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study. Breast Cancer Res Treat. 2012;134:1169–78.
18. Quaglino P, Matthiessen LW, Curatolo P, et al. Predicting patients at risk for pain associated with electrochemotherapy. Acta Oncol. 2015;16:1–9.
19. Larkin JO, Collins CG, Aarons S, et al. Electrochemotherapy. Aspects of preclinical development and early clinical experience. Ann Surg. 2007;245:469–79.
20. Matthiessen LW, Johannesen HH, Hendel HW, et al. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol. 2012;51:713–21.
21. Benevento R, Santoriello A, Perna G, et al. Electrochemotherapy of cutaneous metastases from breast cancer in elderly patients: a preliminary report. BMC Surg. 2012;12(suppl 1):S6.
22. Campana LG, Galuppo S, Valpione S, et al. Bleomycin electrochemotherapy in elderly metastatic breast cancer patients: clinical outcome and management considerations. J Cancer Res Clin Oncol. 2014;140:1557–65.
23. Mali B, Jarm T, Snoj M, et al. Antitumor effectiveness of electrochemotherpay: a systematic review and meta-analysis. Eur J Surg Oncol. 2013;39:4–16.
24. Mali B, Miklavcic D, Campana LG, et al. Tumor size and effectivness of electrochemotherapy. Radiol Oncol. 2013;47:32–41.
25. Matthiesen LW, Johannesen HH, Skougaard K, et al. Dual time point imaging fluorine-18 fluorodeoxyglucose positron emission tomography for evaluation of large loco-regional recurrences of breast cancer treated with electrochemotherapy. Radiol Oncol. 2013;47:358–65.
26. Evangelista L, Mezzato C, Felloni G, et al. Current and future perspectives in diagnostic imaging as a guide to targeted/local therapies in breast cancer recurrence. Q J Nucl Med Mol Imaging. 2013;57:367–80.
27. Chagpar A, Meric-Bernstam F, Hunt KK, et al. Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol. 2003;10:628–34.
28. Robinson AG, Booth CM, Eisenhauer EA. Disease-free survival as an end-point in the treatment of solid tumours—perspectives from clinical trials and clinical practice. Eur J Cancer. 2014;50:2298–302.
29. Siena S, Peeters M, Van Cutsem E, et al. Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab. Br J Cancer. 2007;97:1469–74.
30. Parikh RB, Kirch RA, Smith TJ, et al. Early specialty palliative care: translating data in oncology into practice. N Engl J Med. 2013;369:2347–51.